Foresite Capital Management V, LLC
Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| CG Oncology, Inc.(CGON) | 1,004,050 | 1,004,050 | 0 | 26,105,300 | 40,443,134 | 37.19% | +14,337,834 |
| ALUMIS INC. | 5,779,348 | 5,779,348 | 0 | 17,338,044 | 23,059,599 | 21.21% | +5,721,555 |
| Lyell Immunopharma, Inc. | 406,652 | 477,078 | +70,426 | 3,594,804 | 7,747,747 | 7.12% | +4,152,943 |
| Disc Medicine, Inc.(IRON) | 299,069 | 299,069 | 0 | 15,838,694 | 19,762,480 | 18.17% | +3,923,786 |
| Hims & Hers Health, Inc.(HIMS) | 273,151 | 273,151 | 0 | 13,616,577 | 15,493,125 | 14.25% | +1,876,548 |
| Maze Therapeutics, Inc.(MAZE) | 345,191 | 86,291 | -258,900 | 4,235,494 | 2,237,526 | 2.06% | -1,997,968 |